ACS
EXAS

Archford Capital Strategies’s Exact Sciences EXAS Stock Holding History

Archford Capital Strategies’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,041
Closed -$614K – 355
2025
Q4 		$614K Buy
6,041
+14
+0.2% +$1.12K 0.07% 215
2025
Q3 		$330K Sell
6,027
-20
-0.3% -$999 0.04% 266
2025
Q2 		$321K Buy
+6,047
New +$307K 0.04% 265

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Archford Capital Strategies's EXAS Position: Q1 2026 in Review

Archford Capital Strategies sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,041 shares — an estimated $614K sold.

Archford Capital Strategies first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $614K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Archford Capital Strategies reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Archford Capital Strategies sold 6,041 Exact Sciences shares in Q1 2026, an estimated $614K.
  • Archford Capital Strategies first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
  • Archford Capital Strategies's Exact Sciences position peaked at $614K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Archford Capital Strategies's 13F filing for Q1 2026, filed 15 Apr 2026.